167 related articles for article (PubMed ID: 12029541)
1. Fludarabine-induced eosinophilia: case report.
Voutsadakis IA
Ann Hematol; 2002 May; 81(5):292-3. PubMed ID: 12029541
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.
Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K
Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
Trojan A; Meier R; Licht A; Taverna C
Ann Hematol; 2002 Sep; 81(9):535-7. PubMed ID: 12373357
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
5. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies.
Lärfars G; Udén-Blohmé AM; Samuelsson J
Br J Haematol; 1996 Sep; 94(4):709-12. PubMed ID: 8826898
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
Lam CC; Ma ES; Kwong YL
Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
[TBL] [Abstract][Full Text] [Related]
8. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
[TBL] [Abstract][Full Text] [Related]
9. 2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia.
Robak T; Sysa-Jedrzejowska A; Robak E; Dabkowski J; Blasinska-Morawiec M
J Med; 1997; 28(3-4):199-209. PubMed ID: 9355024
[TBL] [Abstract][Full Text] [Related]
10. Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
Chaker L; Segeren CM; Bot FJ; Maartense E
Eur J Haematol; 2010 Jul; 85(1):91-2. PubMed ID: 20331737
[No Abstract] [Full Text] [Related]
11. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
[TBL] [Abstract][Full Text] [Related]
13. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
14. [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia].
Léonard S; Hulin C; Anxionnat R; Grignon Y; Taillandier L; Vespignani H
Rev Neurol (Paris); 2002 Nov; 158(11):1121-3. PubMed ID: 12451348
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary tuberculosis after fludarabine for chronic lymphocytic leukaemia.
Ghosh K; Sivakumaran M; Murphy P; Chapman CS
Natl Med J India; 1995; 8(6):294-5. PubMed ID: 8520454
[No Abstract] [Full Text] [Related]
16. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
17. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
[TBL] [Abstract][Full Text] [Related]
18. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Martell RE; Peterson BL; Cohen HJ; Petros WP; Rai KR; Morrison VA; Elias L; Shepherd L; Hines J; Larson RA; Schiffer CA; Hurwitz HI
Cancer Chemother Pharmacol; 2002 Jul; 50(1):37-45. PubMed ID: 12111110
[TBL] [Abstract][Full Text] [Related]
19. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
20. Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation.
Patriarca F; Gaidano G; Capello D; Zaja F; Fanin R; Baccarani M
Haematologica; 2000 Sep; 85(9):982-5. PubMed ID: 10980639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]